INTRODUCTION: Metformin-associated lactic acidosis (MALA) is well described in patients
taking therapeutic metformin who develop renal failure or other serious comorbid conditions …

Background Although metformin‐associated lactic acidosis is well described, there is less
information on metformin overdose and whether it is of similar severity. Aims This study aims …

Metformin, widely used in the treatment of diabetes mellitus, is known to cause lactic
acidosis in both therapeutic use and after an overdose. We report the case of a 40-year-old …

There are 20.8 million Americans with diabetes, and metformin is the most commonly
prescribed oral diabetes agent. A review of our metformin experience highlights common …

Objective: Metformin-associated lactic acidosis (MALA) is a complication of metformin
overdose. Recommendations for observation time after an acute ingestion to monitor for …

A new diagnostic paradigm has been proposed to better categorize causes of Metformin-
Associated Lactic Acidosis (MALA). The diagnostic criteria defines a link between Metformin …

STUDY OBJECTIVE: Metformin is known to cause potentially fatal metabolic acidosis with
an increased lactate level in both overdose and therapeutic use. No association between …

Introduction Metformin is a commonly used treatment modality in type 2 diabetes mellitus,
with a well documented side effect of lactic acidosis. In the intensive care setting lactate and …

Inadvertent or intentional metformin overdose can result in death from refractory lactic
acidosis. We report a death from metformin-induced refractory lactic acidosis despite …

Background Metformin-associated lactic acidosis (MALA) is a rare but life-threatening
adverse drug reaction of metformin, the most frequently prescribed medication for patients …